{"result": {"id": "c242a5e7-6580-4156-a329-cfb1689ad01c", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>5-HYDROXYTRYPTAMINE SYNDROME<|>EVENT<|>A potentially life-threatening drug interaction involving excessive serotonin activity)\n##\n(\"entity\"<|>QT PROLONGATION<|>EVENT<|>A cardiac condition that can be caused by certain drug interactions)\n##\n(\"entity\"<|>HYPERKALEMIA<|>EVENT<|>Elevated potassium levels that can result from drug interactions)\n##\n(\"entity\"<|>ANGIONEUROTIC EDEMA<|>EVENT<|>Severe swelling that can be triggered by drug interactions)\n##\n(\"entity\"<|>GASTROINTESTINAL BLEEDING<|>EVENT<|>A serious adverse effect that can occur from drug interactions in elderly patients)\n##\n(\"entity\"<|>INTRACRANIAL HEMORRHAGE<|>EVENT<|>A life-threatening bleeding event that can result from drug interactions)\n##\n(\"entity\"<|>HYPOGLYCEMIC COMA<|>EVENT<|>A severe complication of drug interactions affecting blood sugar levels)\n##\n(\"entity\"<|>HYPERTENSIVE CRISIS<|>EVENT<|>A dangerous blood pressure elevation that can be caused by drug interactions)\n##\n(\"entity\"<|>SEVERE HYPOTENSION<|>EVENT<|>Extremely low blood pressure that can result from drug interactions)\n##\n(\"entity\"<|>ARRHYTHMIA<|>EVENT<|>Abnormal heart rhythms that can be triggered by drug interactions)\n##\n(\"entity\"<|>RESPIRATORY MUSCLE PARALYSIS<|>EVENT<|>A serious adverse effect on breathing from drug interactions)\n##\n(\"entity\"<|>RHABDOMYOLYSIS<|>EVENT<|>Muscle tissue breakdown that can be caused by drug interactions)\n##\n(\"entity\"<|>SEVERE HEPATIC INJURY<|>EVENT<|>Serious liver damage that can result from drug interactions)\n##\n(\"relationship\"<|>5-HYDROXYTRYPTAMINE SYNDROME<|>QT PROLONGATION<|>Both are serious adverse drug interaction events<|>4)\n##\n(\"relationship\"<|>HYPERKALEMIA<|>ANGIONEUROTIC EDEMA<|>Both are potential adverse effects of drug interactions<|>4)\n##\n(\"relationship\"<|>GASTROINTESTINAL BLEEDING<|>INTRACRANIAL HEMORRHAGE<|>Both are bleeding risks from drug interactions<|>5)\n##\n(\"relationship\"<|>HYPOGLYCEMIC COMA<|>HYPERTENSIVE CRISIS<|>Both are metabolic complications from drug interactions<|>4)\n##\n(\"relationship\"<|>SEVERE HYPOTENSION<|>ARRHYTHMIA<|>Both are cardiovascular effects of drug interactions<|>5)\n##\n(\"relationship\"<|>RESPIRATORY MUSCLE PARALYSIS<|>RHABDOMYOLYSIS<|>Both are neuromuscular complications from drug interactions<|>4)\n##\n(\"relationship\"<|>SEVERE HEPATIC INJURY<|>RHABDOMYOLYSIS<|>Both are organ damage events from drug interactions<|>4)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166494, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 753, "prompt_tokens": 2886, "total_tokens": 3639, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2816}, "prompt_cache_hit_tokens": 2816, "prompt_cache_miss_tokens": 70}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �重。\n　2.2    多药合用影响药动学过程  药物在体内吸收、分 布、代谢和排泄各环节均有可能发生药动学相互作用， 最终影响血药浓度，改变其药理作用和毒性强度。参与 药动学相互作用 的机体因素主要包括：（ 1 ）药物代谢酶： Ⅰ相代谢酶如细胞色素 P450（CYP450）酶， Ⅱ相代谢 酶如二磷酸尿苷葡糖醛酸转移酶（UGT ）、谷胱甘肽S- 转 移酶（GST ）和甲基转移酶等；药物代谢酶的基因多态 性也会造成药物代谢速度不同，从而影响疗效和不良反 应。（2 ）药物转运蛋白：如有机阴离子转运多肽 1B1 （OATP1B1 ）、P- 糖蛋白（P-gp ）和有机阳离子转运 体（OCT ）等，抑制或诱导这些转运蛋白会改变药物在 体内的分布和排泄，导致药物相互作用。\n2.3    多药合用影响药效学  多药合用在药效学方面存 在疗效的相加、协同或拮抗作用，或者存在不良反应的 相加作用。药效学的相互作用可以发生在：（ 1 ）受体 激动剂和拮抗剂竞争受体结合；（2 ）神经递质的释放、 灭活和再摄取（ 如 5- 羟色胺综合征）；（3 ）不良反应 的相加，如 QT 间期的延长、高钾血症、血管神经性水 肿等。\n　　老年人对中枢神经系统药物的敏感性增加，对华法  林和肝素的反应更敏感，而对 β- 受体阻滞剂反应降低。 因此，应关注老年人多药联合治疗时药物相互作用带来  的严重不良反应，包括：消化道或颅内出血、低血糖昏  迷、高血压危象、严重低血压、心律失常、呼吸肌麻痹、 骨骼肌溶解、严重肝损害等。\n3    老年人多重用药的风险管理原则［1，10］\n　　医生、药师、患者及其家属均应提高安全用药的认 识，最大限度地减少多药联合治疗给患者带来的药源性 损害。\n3.1    医生  （ 1 ）联合用药应注意剂量个体化。老年人 用药反应的个体差异比年轻人更为突出，用药要遵循从 小剂量开始，逐渐达到适宜的个体最佳剂量。（2 ）联 合用药应“少而精”。能单药治疗，不联合用药；在保 证疗效的情况下，联合用药时尽量减少用药的数量，优 先选择相互作用少的药物。（3 ）根据各种药物时间生 物学和时辰药理学的原理，选择药物各自的最佳服药剂 量和时间，延长联合用药的时间间隔，在保证疗效的同 时，降低药物相互作用的风险。（4 ）向患者告知所处 方药物的不良反应及发生药物相互作用的可能性。\n3\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CYP450<|>ORGANIZATION<|>CYP450 is a phase I metabolic enzyme involved in drug metabolism and interactions)\n##\n(\"entity\"<|>UGT<|>ORGANIZATION<|>UGT is a phase II metabolic enzyme involved in drug metabolism and interactions)\n##\n(\"entity\"<|>GST<|>ORGANIZATION<|>GST is a phase II metabolic enzyme involved in drug metabolism and interactions)\n##\n(\"entity\"<|>OATP1B1<|>ORGANIZATION<|>OATP1B1 is a drug transporter protein that affects drug distribution and excretion)\n##\n(\"entity\"<|>P-GP<|>ORGANIZATION<|>P-gp is a drug transporter protein that affects drug distribution and excretion)\n##\n(\"entity\"<|>OCT<|>ORGANIZATION<|>OCT is a drug transporter protein that affects drug distribution and excretion)\n##\n(\"relationship\"<|>CYP450<|>UGT<|>Both CYP450 and UGT are enzymes involved in drug metabolism<|>5)\n##\n(\"relationship\"<|>CYP450<|>GST<|>Both CYP450 and GST are enzymes involved in drug metabolism<|>5)\n##\n(\"relationship\"<|>UGT<|>GST<|>Both UGT and GST are phase II metabolic enzymes<|>6)\n##\n(\"relationship\"<|>OATP1B1<|>P-GP<|>Both OATP1B1 and P-gp are drug transporter proteins<|>6)\n##\n(\"relationship\"<|>OATP1B1<|>OCT<|>Both OATP1B1 and OCT are drug transporter proteins<|>6)\n##\n(\"relationship\"<|>P-GP<|>OCT<|>Both P-gp and OCT are drug transporter proteins<|>6)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_4e33e7b789a5c6c11f756843e6d7c5da008c790ab0e70637a85188bdd22279b4_v2"}